Related Experiment Video
Updated: Jul 13, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
COVID-19-Associated Acute Asymmetric Hemorrhagic Necrotizing Encephalopathy: A Case Report
Najo Jomaa1, Tarek El Halabi1, Jawad Melhem2
1Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.
Insights
This study reports a case of acute necrotizing encephalopathy (ANE) in a patient with Coronavirus disease 2019 (COVID-19). Neurological complications like ANE highlight the severe impact of SARS-CoV-2 on the central nervous system.
Area of Science:
- Neurology
- Infectious Diseases
- Neuroimaging
Background:
- Coronavirus disease 2019 (COVID-19) is linked to diverse central nervous system complications.
- Investigating rare neurological sequelae of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection is crucial.
Observation:
- A 60-year-old male with COVID-19 developed left-sided weakness post-extubation.
- Brain MRI revealed hemorrhagic rim-enhancing lesions in the thalamus and hippocampus.
- Neuroimaging findings were consistent with a probable variant of acute necrotizing encephalopathy (ANE).
Findings:
- The patient's lesions demonstrated reduced cerebral blood flow and restricted diffusion.
- These findings suggest an immune-mediated process triggered by SARS-CoV-2 infection.
- ANE is a rare but serious neurological complication associated with COVID-19.
Implications:
- COVID-19 can precipitate acute necrotizing encephalopathy, potentially via immune system activation.
- Further research is needed to explore targeted therapies, such as anti-cytokine drugs, for preventing COVID-19-associated ANE.
- This case underscores the importance of recognizing and managing neurological complications in COVID-19 patients.
Abstract:
Background: Coronavirus disease 2019 (COVID-19) has been associated with many neurological complications affecting the central nervous system. Purpose: Our aim was to describe a case of COVID-19 associated with a probable variant of acute necrotizing encephalopathy (ANE). Results: A 60-year-old man who presented with a 3-day history of dyspnea, fever, and cough tested positive for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). Five days following his admission, the patient was intubated secondary to respiratory failure. Following his extubation 16 days later, he was found to have a left-sided weakness. Magnetic resonance imaging (MRI) of the brain showed hemorrhagic rim-enhancing lesions involving the right thalamus, left hippocampus, and left parahippocampal gyrus. These lesions showed decreased relative cerebral blood flow on MR perfusion and restricted on diffusion-weighted imaging. These neuroimaging findings were consistent with ANE. The left-sided weakness gradually improved over the subsequent weeks. Conclusions: We concluded that COVID-19 can be associated with ANE, a condition believed to be the result of an immune-mediated process with activation of the innate immune system. Future studies must address whether biological drugs targeting the pro-inflammatory cytokines could prevent the development of this condition.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

